SCHEMBL7048693

SCHEMBL7048693

CCCCCCCCCCCCCCOC(=O)C1=C(CBr)NC(CBr)=C(C(=O)OCCCCCCCCCCCCCC)C1c1ccccc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.51
TSHR P16473 2/20 0.51
LMNA P02545 1/20 0.51
CACNA1F O60840 1/20 0.49
CACNA1D Q01668 1/20 0.49
CACNA1S Q13698 1/20 0.49
CACNA1C Q13936 1/20 0.49
KDM4E B2RXH2 1/20 0.49
POLB P06746 1/20 0.49
HSD17B10 Q99714 1/20 0.49
TP53 P04637 1/20 0.49
CYP3A4 P08684 1/20 0.49
MAPK1 P28482 1/20 0.49
PPARG P37231 3/20 0.48
ADORA3 P0DMS8 1/20 0.46
MMP1 P03956 1/20 0.45
MMP9 P14780 1/20 0.45
MMP12 P39900 1/20 0.45
NPC1 O15118 1/20 0.45
MAPT P10636 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7044561 1.00 ALDH1A1 (0.51) ALDH1A1TSHRLMNACACNA1FCACNA1D
SCHEMBL7048080 1.00 ALDH1A1 (0.51) ALDH1A1TSHRLMNACACNA1FCACNA1D
SCHEMBL7044551 1.00 ALDH1A1 (0.51) ALDH1A1TSHRLMNACACNA1FCACNA1D
Bromide SCHEMBL7044932 0.85 PPARG (0.46) ALDH1A1TSHRLMNACACNA1FCACNA1D
Bromide SCHEMBL7044582 0.85 PPARG (0.46) ALDH1A1TSHRLMNACACNA1FCACNA1D
Bromide SCHEMBL7041639 0.85 PPARG (0.46) ALDH1A1TSHRLMNACACNA1FCACNA1D
Bromide SCHEMBL7044895 0.85 PPARG (0.46) ALDH1A1TSHRLMNACACNA1FCACNA1D
SCHEMBL7047706 0.84 CACNA1F (0.66) ALDH1A1TSHRLMNACACNA1FCACNA1D
SCHEMBL10830248 0.84 CACNA1F (0.66) ALDH1A1TSHRLMNACACNA1FCACNA1D
SCHEMBL7045697 0.79 KDM4E (0.53) ALDH1A1TSHRLMNACACNA1FCACNA1D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030064954-A1 Cationic amphiphilic 1,4-dihydropyridine derivatives useful for delivery of nucleotide containing compounds SPONDULI SERVICES, LTD. (AU) 2003-04-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030064954-A1 Cationic amphiphilic 1,4-dihydropyridine derivatives useful for delivery of nucleotide containing compounds ACIN1, DNA2, KPNA1 ALDH1A1 2344/4885TSHR 4680/4885LMNA 603/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.